Immune checkpoint inhibitors in EGFR-mutation positive TKI-treated patients with advanced non-small-cell lung cancer network meta-analysis

Egfr Mutation ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Small Cell ◽

Small Cell Lung ◽

Cancer Network

Association Between EGFR Mutation Status and Immune Checkpoint Inhibitors and PD-L1 Expression in Non-Small-Cell Lung Cancer: A Meta-Analysis

SSRN Electronic Journal ◽

10.2139/ssrn.3792115 ◽

2021 ◽

Author(s):

Huimin Yang ◽

Jinxiu Zhu ◽

Rendong Xiao ◽

Yuhang Liu ◽

Fanglin Yu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Immune Checkpoint ◽

Egfr Mutation ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Small Cell ◽

Small Cell Lung ◽

Mutation Status

Impact of treatment timing and sequence of immune checkpoint inhibitors and anti-angiogenic agents for advanced non-small cell lung cancer: A systematic review and meta-analysis

Lung Cancer ◽

10.1016/j.lungcan.2021.11.008 ◽

2021 ◽

Author(s):

Kinnosuke Matsumoto ◽

Takayuki Shiroyama ◽

Tomoki Kuge ◽

Kotaro Miyake ◽

Yuji Yamamoto ◽

...

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Small Cell Lung Cancer ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Small Cell ◽

Small Cell Lung ◽

Treatment Timing

The optimal immune checkpoint inhibitors combined with chemotherapy for advanced non-small-cell lung cancer: a systematic review and meta-analysis

Clinical & Translational Oncology ◽

10.1007/s12094-020-02502-8 ◽

2020 ◽

Author(s):

Y. Yang ◽

H. Luo ◽

X. L. Zheng ◽

H. Ge

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Small Cell ◽

Clinical Efficacy of Immune Checkpoint Inhibitors in Older Non-small-Cell Lung Cancer Patients: A Meta-Analysis

Frontiers in Oncology ◽

10.3389/fonc.2020.558454 ◽

2020 ◽

Vol 10 ◽

Author(s):

You-Meng Sun ◽

Ying Wang ◽

Xin-Xing Sun ◽

Jing Chen ◽

Zhi-Ping Gong ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients

Predictors of Survival Benefit From Immune Checkpoint Inhibitors in Patients With Advanced Non–small-cell Lung Cancer: A Systematic Review and Meta-analysis

Clinical Lung Cancer ◽

10.1016/j.cllc.2019.11.004 ◽

2020 ◽

Vol 21 (2) ◽

pp. 106-113.e5 ◽

Cited By ~ 2

Author(s):

Jacques Raphael ◽

Anupam Batra ◽

Gabriel Boldt ◽

Prakesh S. Shah ◽

Phillip Blanchette ◽

...

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Small Cell Lung Cancer ◽

Immune Checkpoint ◽

Survival Benefit ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Small Cell ◽

P2.07-055 Indirect Comparison between Immune-Checkpoint Inhibitors for 2nd Line Non-Small Cell Lung Cancer – a Network Meta-Analysis

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2017.09.1311 ◽

2017 ◽

Vol 12 (11) ◽

pp. S2150 ◽

Cited By ~ 1

Author(s):

P. Tan ◽

P. Aguiar ◽

B. Haaland ◽

G. Lopes

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Indirect Comparison ◽

Small Cell ◽

EGFR mutation positive non-small cell lung cancer: can we identify predictors of benefit from immune checkpoint inhibitors

Annals of Translational Medicine ◽

10.21037/atm.2017.08.14 ◽

2017 ◽

Vol 5 (21) ◽

pp. 424-424 ◽

Cited By ~ 3

Author(s):

Ying Wang ◽

Peter Ellis

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Immune Checkpoint ◽

Egfr Mutation ◽

Checkpoint Inhibitors ◽

Small Cell ◽

Survival benefit of immune checkpoint inhibitors according to the histology in non-small-cell lung cancer: A meta-analysis and review

Oncotarget ◽

10.18632/oncotarget.17213 ◽

2017 ◽

Vol 8 (31) ◽

pp. 51779-51785 ◽

Cited By ~ 7

Author(s):

Bum Jun Kim ◽

Jung Han Kim ◽

Hyeong Su Kim

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Immune Checkpoint ◽

Survival Benefit ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Small Cell ◽

The Differences in the Safety and Tolerability of Immune Checkpoint Inhibitors as Treatment for Non–Small Cell Lung Cancer and Melanoma: Network Meta-Analysis and Systematic Review

Frontiers in Pharmacology ◽

10.3389/fphar.2019.01260 ◽

2019 ◽

Vol 10 ◽

Cited By ~ 4

Author(s):

Qing-Qing Chai ◽

Jiang-Yang Du ◽

Jun Zhu ◽

Bin Wu

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Small Cell ◽

Meta-analysis exploring the effect of oncogenic driver mutations on outcome of metastatic non-small cell lung cancer (mNSCLC) patients (pts) treated with immune checkpoint inhibitors (ICI) or docetaxel (doc).

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.9029 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 9029-9029

Author(s):

Abena Agyeman ◽

Jonathon Joseph Vallejo ◽

Adrian Myers ◽

Gideon Michael Blumenthal

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Small Cell ◽

Driver Mutations ◽

Small Cell Lung ◽

Oncogenic Driver